PatientsVille.com Logo

PatientsVille

Terbinafine Side Effects

Common Terbinafine Side Effects

The most commonly reported Terbinafine side effects (click to view or check a box to report):

Dysgeusia (85)
Ageusia (80)
Dizziness (61)
Rash (60)
Depression (57)
Nausea (51)
Malaise (47)
Pruritus (44)
Headache (41)
Anxiety (36)
Weight Decreased (33)
Urticaria (33)
Fatigue (32)
Liver Function Test Abnormal (32)
Erythema (32)
Paraesthesia (31)
Skin Exfoliation (29)
Myalgia (28)
Diarrhoea (28)
Panic Attack (27)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Terbinafine Side Effects Reported to FDA

The following Terbinafine reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Terbinafine on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Pancreatitis, Cholelithiasis, Gastrointestinal Inflammation, Liver Function Test Abnormal
on Mar 10, 2014 Male from GB , 66 years of age, weighting 121.3 lb, was diagnosed with and was treated with Terbinafine. Directly after, patient experienced the unwanted or unexpected Terbinafine side effects: pancreatitis, cholelithiasis, gastrointestinal inflammation, liver function test abnormal. Terbinafine dosage: 250 Mg, Unk.
Associated medications used:
  • Covonia Bronchial (Unk Ukn, Unk)
  • Ibuprofen (Unk Ukn, Unk)
Patient was hospitalized.

Blister, Rash Macular
Patient was taking Terbinafine (terbinafine). Patient felt the following Terbinafine side effects: blister, rash macular on Mar 05, 2014 from GB Additional patient health information: Male , 31 years of age, weighting 140.5 lb, . Terbinafine (terbinafine) dosage: N/A.
Multiple prescriptions taken:
  • Betamethasone Valerate (betamethasone Valerate)
  • E45 (akwa Tears /01635801/)
  • Mometasone (mometasone)


Biliary Cirrhosis Primary, Urticaria, Tryptase Increased, Pruritus, Autoimmune Disorder, Hepatic Enzyme Increased
Adverse event was reported on Feb 27, 2014 by a Female taking Terbinafine (Dosage: N/A) was diagnosed with and. Location: CH , 29 years of age, After Terbinafine was administered, patient encountered several Terbinafine side effects: biliary cirrhosis primary, urticaria, tryptase increased, pruritus, autoimmune disorder, hepatic enzyme increased.

Blister, Rash Macular, Rash Pustular
on Feb 26, 2014 Male from GB , 31 years of age, weighting 140.5 lb, was treated with Terbinafine. Directly after, patient experienced the unwanted or unexpected Terbinafine side effects: blister, rash macular, rash pustular. Terbinafine dosage: N/A.
Associated medications used:
  • Betamethasone Valerate
  • E45
  • Mometasone



Blister, Rash Pustular, Rash Macular
on Feb 25, 2014 Male from GB , 31 years of age, weighting 140.5 lb, was treated with Terbinafine. Patient felt the following Terbinafine side effects: blister, rash pustular, rash macular. Terbinafine dosage: Unk Ukn, Unk.
Multiple prescriptions taken:
  • Betamethasone Valerate (Unk Ukn, Unk)
  • E45 (Unk Ukn, Unk)
  • Mometasone (Unk Ukn, Unk)
  • Cetraben (Unk Ukn, Unk)


Subacute Cutaneous Lupus Erythematosus, Erythema Multiforme
Patient was taking Terbinafine. After Terbinafine was administered, patient encountered several Terbinafine side effects: subacute cutaneous lupus erythematosus, erythema multiforme on Mar 21, 2014 from DK Additional patient health information: Male , 78 years of age, . Terbinafine dosage: N/A.
Multiple concurrent drugs taken:
  • Lansoprazole (Unk)


Epilepsy
Adverse event was reported on Feb 21, 2014 by a Male taking Terbinafine (Dosage: N/A) was diagnosed with and. Location: GB , 56 years of age, Directly after, patient experienced the unwanted or unexpected Terbinafine side effects: epilepsy.
Associated medications used:
  • Sildenafil


Dysgeusia, Headache, Viith Nerve Paralysis
on Feb 18, 2014 Female from GB , 48 years of age, weighting 229.3 lb, was diagnosed with and was treated with Terbinafine (terbinafine). Patient felt the following Terbinafine side effects: dysgeusia, headache, viith nerve paralysis. Terbinafine (terbinafine) dosage: N/A. Patient was hospitalized.

Epilepsy
on Feb 20, 2014 Male from GB , 56 years of age, was diagnosed with and was treated with Terbinafine. After Terbinafine was administered, patient encountered several Terbinafine side effects: epilepsy. Terbinafine dosage: 250 Milligram Daily;.
Multiple concurrent drugs taken:
  • Sildenafil


Viith Nerve Paralysis, Headache, Dysgeusia
Patient was taking Terbinafine Hydrochloride. Directly after, patient experienced the unwanted or unexpected Terbinafine side effects: viith nerve paralysis, headache, dysgeusia on Feb 19, 2014 from GB Additional patient health information: Female , 48 years of age, weighting 229.3 lb, was diagnosed with and. Terbinafine Hydrochloride dosage: N/A. Patient was hospitalized.

Depression, Catatonia
Adverse event was reported on Feb 18, 2014 by a Male taking Terbinafine (Dosage: 1 Keer Per Dag 1 Stuk(s)) was diagnosed with and. Location: NL , 64 years of age, Patient felt the following Terbinafine side effects: depression, catatonia. Patient was hospitalized.

Hypersensitivity, Depression, Skin Disorder, Skin Exfoliation
on Feb 14, 2014 Male from NL , 64 years of age, weighting 176.4 lb, was diagnosed with and was treated with Terbinafine. After Terbinafine was administered, patient encountered several Terbinafine side effects: hypersensitivity, depression, skin disorder, skin exfoliation. Terbinafine dosage: 1 Keer Per Dag 1 Stuk(s).
Multiple concurrent drugs taken:
  • Simvastatine
  • Acetylsalicylzuur
Patient was hospitalized.

Viith Nerve Paralysis, Headache, Dysgeusia
on Feb 13, 2014 Female from GB , 48 years of age, weighting 229.3 lb, was diagnosed with and was treated with Terbinafine. Directly after, patient experienced the unwanted or unexpected Terbinafine side effects: viith nerve paralysis, headache, dysgeusia. Terbinafine dosage: N/A. Patient was hospitalized.

Epilepsy
Patient was taking Terbinafine. Patient felt the following Terbinafine side effects: epilepsy on Feb 11, 2014 from GB Additional patient health information: Male , 56 years of age, was diagnosed with and. Terbinafine dosage: 250 Mg, Qd.
Multiple prescriptions taken:
  • Sildenafil (Unk Ukn, Unk)


Viith Nerve Paralysis, Headache, Dysgeusia
Adverse event was reported on Feb 07, 2014 by a Female taking Terbinafine (Dosage: N/A) was diagnosed with and. Location: GB , 48 years of age, weighting 229.3 lb, After Terbinafine was administered, patient encountered several Terbinafine side effects: viith nerve paralysis, headache, dysgeusia. Patient was hospitalized.

Stevens-johnson Syndrome, Eczema, Insomnia, Stress
on Jan 30, 2014 Male from GB , 78 years of age, was diagnosed with and was treated with Terbinafine. Directly after, patient experienced the unwanted or unexpected Terbinafine side effects: stevens-johnson syndrome, eczema, insomnia, stress. Terbinafine dosage: N/A.

Pulse Pressure Increased, Arteritis, Muscle Spasms, Pain Of Skin, Headache
on Jan 28, 2014 Female from GB , 62 years of age, weighting 154.3 lb, was diagnosed with and was treated with Terbinafine. Patient felt the following Terbinafine side effects: pulse pressure increased, arteritis, muscle spasms, pain of skin, headache. Terbinafine dosage: 250 Mg, Unk.
Multiple prescriptions taken:
  • Amitriptyline (10 Mg, Qd At Night)


Dysgeusia, Ageusia, Food Aversion, Aptyalism, Dysphagia, Oropharyngeal Pain
Patient was taking Terbinafine Hcl. After Terbinafine was administered, patient encountered several Terbinafine side effects: dysgeusia, ageusia, food aversion, aptyalism, dysphagia, oropharyngeal pain on Jan 24, 2014 from US Additional patient health information: Female , 65 years of age, weighting 137.0 lb, . Terbinafine Hcl dosage: N/A.
Multiple concurrent drugs taken:
  • Estradiol
  • Diltiazem Hcl
  • Hydrochlorothiazide
  • Baby Aspirin
  • Citracal D
  • Centrum Specialist Heart


Rash, Excoriation, Dry Skin, Erythema
Adverse event was reported on Jan 17, 2014 by a Female taking Terbinafine (terbinafine) (Dosage: N/A) was diagnosed with and. Location: GB , 88 years of age, Directly after, patient experienced the unwanted or unexpected Terbinafine side effects: rash, excoriation, dry skin, erythema.
Associated medications used:
  • Aspirin (acetylsalicylic Acid)
  • Diprobase (diprobase)
  • E45 (akwa Tears)
  • Enalapril (enalapril)
  • Flucloxacillin ( Flucloxacillin)
  • Metformin (metformin)
  • Miconazole (miconazole)
  • Paracetamol (paracetamol)
Patient was hospitalized.

Arteritis, Pain, Headache, Pulse Pressure Increased, Pain Of Skin, Muscle Spasms
on Jan 24, 2014 Female from GB , 62 years of age, weighting 154.3 lb, was diagnosed with and was treated with Terbinafine. Patient felt the following Terbinafine side effects: arteritis, pain, headache, pulse pressure increased, pain of skin, muscle spasms. Terbinafine dosage: N/A.
Multiple prescriptions taken:
  • Amitriptyline


Dermatitis Exfoliative, Arthralgia, Erythema, Renal Failure Acute, Renal Impairment, Local Swelling
on Jan 22, 2014 Male from GB , 77 years of age, weighting 204.4 lb, was diagnosed with and was treated with Terbinafine. After Terbinafine was administered, patient encountered several Terbinafine side effects: dermatitis exfoliative, arthralgia, erythema, renal failure acute, renal impairment, local swelling. Terbinafine dosage: N/A.
Multiple concurrent drugs taken:
  • Flucloxacillin
  • Penicillin V
  • Atorvastatin
  • Clopidogrel
  • Metformin
Patient was hospitalized and became disabled.

Erythema, Dry Skin, Excoriation
Patient was taking Terbinafine. Directly after, patient experienced the unwanted or unexpected Terbinafine side effects: erythema, dry skin, excoriation on Jan 17, 2014 from GB Additional patient health information: Female , 88 years of age, was diagnosed with and. Terbinafine dosage: N/A.
Associated medications used:
  • Aspirin
  • Diprobase
  • E45
  • Enalapril
  • Flucloxacillin
  • Metformin
  • Miconazole
  • Paracetamol
Patient was hospitalized.

Orchitis, Dermatitis Exfoliative, Groin Pain, Renal Failure Acute, Hepatic Function Abnormal, Thrombocytopenia, Atrial Fibrillation, Respiratory Failure
Adverse event was reported on Jan 14, 2014 by a Male taking Terbinafine (Dosage: N/A) was diagnosed with and. Location: GB , 57 years of age, Patient felt the following Terbinafine side effects: orchitis, dermatitis exfoliative, groin pain, renal failure acute, hepatic function abnormal, thrombocytopenia, atrial fibrillation, respiratory failure.
Multiple prescriptions taken:
  • Phenobarbital (phenobarbital)


Renal Failure Acute
on Jan 14, 2014 Male from FR , 25 years of age, was treated with Terbinafine. After Terbinafine was administered, patient encountered several Terbinafine side effects: renal failure acute. Terbinafine dosage: N/A. Patient was hospitalized.

Dermatitis Exfoliative, Thrombocytopenia, Hepatic Function Abnormal, Respiratory Failure, Renal Failure Acute, Groin Pain, Orchitis, Atrial Fibrillation
on Jan 14, 2014 Male from GB , 57 years of age, weighting 198.4 lb, was diagnosed with and was treated with Terbinafine. Directly after, patient experienced the unwanted or unexpected Terbinafine side effects: dermatitis exfoliative, thrombocytopenia, hepatic function abnormal, respiratory failure, renal failure acute, groin pain, orchitis, atrial fibrillation. Terbinafine dosage: 250 Milligram Daily; (note: 13 Of 28 Tablets Supplied Remain I.e. Not Taken).
Associated medications used:
  • Phenobarbital


1 of 42 

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:

     

    Side Effects

    Scale

    Date & Time

    Other Medicine(s) or Treatment(s)

     

     

     

     

    Scale: 1 = very mild to 10 = very bad


    Track Online

  • User Sign In
  • Register to track your side effects

  • You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Discuss Terbinafine Side Effects

    Did You Have a Terbinafine Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Terbinafine for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Safety Alerts, Active Ingredients, Usage Information

    Alternative TERBINAFINE Names:TERBINAFI

    Active Ingredient: TERBINAFI

    More About Terbinafine

    Side Effects reported to FDA: 1036

    Terbinafine safety alerts: 2001 2000

    Reported deaths: 23

    Reported hospitalizations: 126

    Lamisil (terbinafine hydrochloride)

    Sporanox (itraconazole)

    Audience: Dermatologists and other healthcare professionals

    FDA is issuing a public health advisory concerning Sporanox and Lamisil, systemic drug therapies to treat onychomycosis (fungal nail infections). Healthcare professionals are notified of the possible association of serious cardiac adverse events with the administration of Sporanox and hepatic adverse events with the administration of both Sporanox and Lamisil. New labeling for both Sporanox and Lamisil recommends that healthcare providers obtain nail specimens for laboratory testing prior to prescribing the medications for onychomycosis to confirm the diagnosis. FDA's concerns do NOT apply to the over-the-counter versions of Lamisil, which are topical creams.

    [May 11, 2001 - Letter - Novartis Pharmaceuticals Corp.]
    [May 09, 2001 - Letter - Janssen Pharmaceutica Products, L.P.]
    [May 09, 2001 - Public Health Advisory - FDA]
    [May 09, 2001 - Questions and Answers - FDA]
    [May 09, 2001 - Revised Sporanox Capsules Label - Janssen Pharmaceutica Products, L.P.]

     

    Latest Terbinafine clinical trials